Signaling pathways
-
BA1903 BRD-6929Summary: BRD-6929 is a class I histone deacetylase and brain permeability selective inhibitor. - BA1904 MitoguazoneSummary: Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) is a synthetic polycarbony derivative with potent antitumor activity.
- BA1908 MS417Summary: MS417 is a selective inhibitor of BET-specific proteins.
- BA1909 GPI-1046Summary: GPI-1046, an immunoaffinity ligand without antibiotic effects, reduces ethanol intake by upregulating glutamate transporter protein 1 in the PFC and NAc core.
- BA1912 LDC4297Summary: LDC4297 is a selective inhibitor.
- BA1913 TrilobatinSummary: Trilobatin is a sweetener derived from Rehd, Trilobatin is an inhibitor that targets the Gp41 envelope protein.
- BA1914 ZL0580Summary: ZL0580 is a structural analog of ZL0590 and induces epitope inhibition by selective binding to the structural domain of BD1.
- BA1915 FosamprenavirSummary: Fosamprenavir (Amprenavirphosphate; GW433908) is a phosphate precursor of the antiretroviral protease inhibitor Amprenavir with improved solubility.
- BA1916 DiphyllinSummary: Diphyllin, an arylnaphthalene lignan, is a potent inhibitor.
- BA1919 RabdosiinSummary: Rabdosiin is a caffeic acid tetramer.